We evaluated adipogenic and angiogenic activities by immunofluorescence and observed a higher number of intact perilipin-positive mature adipocytes in the GSH-treated group than in the control group
What to Expect While on GLP-1 Therapy Like any medication, GLP-1 injections can cause temporary side effects, most often including mild nausea, fatigue, or digestive changes
Cochrane Database of Systematic Reviews , Oct 18 2004, (4): CD000980
Evidence quality assessment Strong evidence: BPC-157 accelerates tendon healing in rats (multiple independent studies, consistent results, large effect sizes)
Medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC Updated March 24, 2026 Book Consultation WHAT IS BPC-157
More Info Physical Appearance Stability Solubility Amino Acid Sequence Background Survodutide is a dual agonist targeting both the GLP-1 and Glucagon receptors